AB
ENTA icon

Amalgamated Bank’s Enanta Pharmaceuticals ENTA Stock Holding History

Amalgamated Bank’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-857
Closed -$14K – 1996
2025
Q4 		$14K Buy
857
+190
+28% +$2.41K ﹤0.01% 2274
2025
Q3 		$8K Hold
667
– – ﹤0.01% 2553
2025
Q2 		$5K Hold
667
– – ﹤0.01% 2729
2025
Q1 		$4K Hold
667
– – ﹤0.01% 2713
2024
Q4 		$4K Hold
667
– – ﹤0.01% 2782
2024
Q3 		$7K Hold
667
– – ﹤0.01% 2609
2024
Q2 		$9K Hold
667
– – ﹤0.01% 2502
2024
Q1 		$12K Sell
667
-1,208
-64% -$16K ﹤0.01% 2352
2023
Q4 		$18K Sell
1,875
-198
-10% -$1.84K ﹤0.01% 2697
2023
Q3 		$23K Sell
2,073
-5,565
-73% -$89.6K ﹤0.01% 2577
2023
Q2 		$163K Sell
7,638
-646
-8% -$19K ﹤0.01% 1895
2023
Q1 		$335K Sell
8,284
-597
-7% -$28.5K ﹤0.01% 1597
2022
Q4 		$413K Hold
8,881
– – ﹤0.01% 1552
2022
Q3 		$461K Buy
8,881
+399
+5% +$23.3K ﹤0.01% 1472
2022
Q2 		$401K Buy
8,482
+86
+1% +$4.67K ﹤0.01% 1563
2022
Q1 		$598K Sell
8,396
-352
-4% -$22.9K ﹤0.01% 1470
2021
Q4 		$654K Sell
8,748
-256
-3% -$20.1K ﹤0.01% 1442
2021
Q3 		$512K Sell
9,004
-149
-2% -$7.37K ﹤0.01% 1569
2021
Q2 		$403K Buy
+9,153
New +$448K ﹤0.01% 1747
2020
Q1 		– Sell
-3,348
Closed -$207K – 1711
2019
Q4 		$207K Buy
+3,348
New +$208K ﹤0.01% 1623
2019
Q3 		– Sell
-3,228
Closed -$272K – 1784
2019
Q2 		$272K Buy
3,228
+492
+18% +$44.3K 0.01% 1411
2019
Q1 		$261K Buy
+2,736
New +$245K 0.01% 1348
2018
Q3 		– Sell
-2,714
Closed -$315K – 1501
2018
Q2 		$315K Buy
+2,714
New +$271K 0.01% 1292

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Amalgamated Bank's ENTA Position: Q1 2026 in Review

Amalgamated Bank sold out of Enanta Pharmaceuticals (ENTA) in Q1 2026, closing a stake of 857 shares — an estimated $14K sold.

Amalgamated Bank first reported a position in ENTA in Q2 2018 and held it in 23 quarters. The position peaked at $654K in Q4 2021. 133 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Amalgamated Bank reported no remaining Enanta Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 857 Enanta Pharmaceuticals shares in Q1 2026, an estimated $14K.
  • Amalgamated Bank first reported a position in Enanta Pharmaceuticals in Q2 2018 and held it in 23 quarters.
  • Amalgamated Bank's Enanta Pharmaceuticals position peaked at $654K in Q4 2021.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.